Early Ventricular Septal Defect Closure Prevents the Progression of Aortic Regurgitation: A Long-Term Follow-Up Study

Genichiro Sotodate1, Kotaro Oyama2, Hirofumi Saiki2

  • 1Department of Pediatrics, Iwate Medical University, 1-1-1 Idaidori, Yahaba-cho, Shiwa-gun, Morioka, Iwate, 028-3694, Japan. gsotodat@iwate-med.ac.jp.

Insights

Early closure of ventricular septal defects (VSD) in pediatric patients with aortic regurgitation (AR) prevents AR progression long-term. This study confirms early VSD closure effectively manages AR, avoiding aortic valve replacement in most cases.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease
  • Cardiac Surgery

Background:

  • Ventricular septal defect (VSD) closure is recommended early for pediatric patients with aortic regurgitation (AR) to prevent progression.
  • Long-term data on the efficacy of early VSD closure in preventing AR progression are limited.

Purpose of the Study:

  • To evaluate the long-term outcomes (≥10 years) of pediatric patients who underwent early VSD closure after AR diagnosis.
  • To determine if early VSD closure prevents the progression of AR.

Main Methods:

  • Retrospective cohort study of 42 pediatric patients with VSD and AR.
  • VSD closure performed at a median age of 2.9 years, with a median follow-up of 13.1 years.
  • Analysis of AR progression, need for aortic valve replacement, and mortality.

Main Results:

  • None of the 33 patients followed for ≥10 years required aortic valve replacement; no mortality was observed.
  • AR improved or remained stable in most patients, with only one experiencing progression.
  • VSD size, time to surgery, and age at surgery did not predict persistent postoperative AR.

Conclusions:

  • Early VSD closure in pediatric patients with less than moderate preoperative AR can prevent AR progression.
  • This strategy effectively eliminates the need for aortic valve replacement and valvuloplasty in the long term.
  • Early intervention for VSD in the context of AR offers favorable long-term cardiac outcomes.

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
132
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
99
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
142
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
79
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
122
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
110